Saturday, January 24, 2004 11:52:20 PM
DNAPrint Obtains a Supply Agreement on the LNA Technology From Exiqon
2002-08-27 DNAPrint genomics, Inc. announced that it has obtained a non-exclusive right of supply from the Danish company Exiqon A/S to incorporate Locked Nucleic Acid (LNA(TM)) technology into certain of its pharmacogenomics and forensics tests.
DNAPrint kits use small DNA probes to query specific single nucleotide polymorphisms (SNPs) within an individual's genome. The probes contain molecular "addresses" that targets each particular SNP much like a street address targets a postal letter. Most kits made today contain natural DNA; however there are a number of technical advantages associated with using artificially modified DNA molecules instead. The supply agreement signed today enables DNAPrint to use a specially modified DNA called LNA(TM) in the construction of its test kits. Exiqon holds the patent for the LNA(TM) technology.
Ann
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM